Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
But that doesn't mean they have to come off the drugs. As with all pills, it's about weighing the pros and cons. Quite aside from the dementia worries, if a patient ... shock is used to stimulate ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
Seeing the same GP each time has its advantages, and it is more important than it may seem. A milestone review examining 1.4 ...
which looked at the drug in Alzheimer’s disease. But Axovant said it will continue to develop nelotanserin to treat hallucinations in patients with Parkinson’s disease dementia, and is ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...